Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For additional information, please contact the BMS oncology clinical trial information service at 855-216-0126 or email MyCancerStudyConnect@emergingmed.com. Please visit www.BMSStudyConnect.com for more information on clinical trial participation.
Non-Squamous, Non-Small Cell Lung Cancer
Recurrent/Stage IV Non-small cell lung cancer (NSCLC)
Eastern Cooperative Oncology Group (ECOG) 0 or 1
Not progressing after 4 cycles of a platinum-based first line chemotherapy
You may not be if
Brain Metastases (unless stable)
Autoimmune Diseases
Clareo Health | Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer
